rs143853590

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_005921.2(MAP3K1):​c.1846G>A​(p.Gly616Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000994 in 1,614,128 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: 𝑓 0.00074 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 2 hom. )

Consequence

MAP3K1
NM_005921.2 missense

Scores

3
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts P:1B:2

Conservation

PhyloP100: 4.21

Publications

12 publications found
Variant links:
Genes affected
MAP3K1 (HGNC:6848): (mitogen-activated protein kinase kinase kinase 1) The protein encoded by this gene is a serine/threonine kinase and is part of some signal transduction cascades, including the ERK and JNK kinase pathways as well as the NF-kappa-B pathway. The encoded protein is activated by autophosphorylation and requires magnesium as a cofactor in phosphorylating other proteins. This protein has E3 ligase activity conferred by a plant homeodomain (PHD) in its N-terminus and phospho-kinase activity conferred by a kinase domain in its C-terminus. [provided by RefSeq, Mar 2012]
MAP3K1 Gene-Disease associations (from GenCC):
  • 46,XY sex reversal 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • breast cancer
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • 46,XY complete gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • 46,XY partial gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.043625057).
BP6
Variant 5-56875191-G-A is Benign according to our data. Variant chr5-56875191-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 30145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 112 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAP3K1NM_005921.2 linkc.1846G>A p.Gly616Arg missense_variant Exon 10 of 20 ENST00000399503.4 NP_005912.1 Q13233
MAP3K1XM_047417218.1 linkc.1846G>A p.Gly616Arg missense_variant Exon 10 of 18 XP_047273174.1
MAP3K1XM_047417219.1 linkc.1435G>A p.Gly479Arg missense_variant Exon 11 of 21 XP_047273175.1
MAP3K1XM_047417220.1 linkc.1435G>A p.Gly479Arg missense_variant Exon 11 of 21 XP_047273176.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAP3K1ENST00000399503.4 linkc.1846G>A p.Gly616Arg missense_variant Exon 10 of 20 1 NM_005921.2 ENSP00000382423.3 Q13233

Frequencies

GnomAD3 genomes
AF:
0.000736
AC:
112
AN:
152182
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000912
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000610
AC:
152
AN:
249150
AF XY:
0.000651
show subpopulations
Gnomad AFR exome
AF:
0.000258
Gnomad AMR exome
AF:
0.000928
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000464
Gnomad NFE exome
AF:
0.000956
Gnomad OTH exome
AF:
0.000827
GnomAD4 exome
AF:
0.00102
AC:
1493
AN:
1461828
Hom.:
2
Cov.:
32
AF XY:
0.00101
AC XY:
734
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.00105
AC:
47
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86258
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53402
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.00123
AC:
1365
AN:
1111992
Other (OTH)
AF:
0.00109
AC:
66
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
84
168
252
336
420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000735
AC:
112
AN:
152300
Hom.:
0
Cov.:
32
AF XY:
0.000712
AC XY:
53
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41564
American (AMR)
AF:
0.00275
AC:
42
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000912
AC:
62
AN:
68008
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00109
Hom.:
0
Bravo
AF:
0.00117
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000507
AC:
2
ESP6500EA
AF:
0.00120
AC:
10
ExAC
AF:
0.000496
AC:
60
EpiCase
AF:
0.000709
EpiControl
AF:
0.000830

ClinVar

Significance: Likely benign
Submissions summary: Pathogenic:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

46,XY sex reversal 6 Pathogenic:1Benign:1
Dec 15, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 10, 2010
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Hereditary cancer-predisposing syndrome Benign:1
Apr 09, 2024
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
16
DANN
Benign
0.94
DEOGEN2
Benign
0.085
T
Eigen
Benign
-0.66
Eigen_PC
Benign
-0.53
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.044
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
4.2
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.37
N
REVEL
Uncertain
0.38
Sift
Uncertain
0.014
D
Sift4G
Benign
0.40
T
Polyphen
0.026
B
Vest4
0.30
MutPred
0.085
Gain of methylation at G616 (P = 0.026);
MVP
0.95
MPC
0.30
ClinPred
0.015
T
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.067
gMVP
0.25
Mutation Taster
=33/67
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143853590; hg19: chr5-56171018; COSMIC: COSV106114311; API